CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia.

CONCLUSION: These findings indicate that polymorphic CYP1A1 and CYP2D6 genes affect the susceptibility to CML. PMID: 32418524 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32418524?dopt=Abstract

Source: Current Cancer Drug Targets - May 16, 2020 Category: Cancer & Oncology Authors: Idris HM, Khalil HB, Mills J, Elderdery AY Tags: Curr Cancer Drug Targets Source Type: research